Faculty – Medical Imaging in Clinical Research

Jianqing Chen
PET and Molecular Imaging, PFIZER

Debbie N. Coté, RN
Director, Clinical Operations, NEKTAR THERAPEUTICS

Neeta Fahey
Clinical Imaging Operations, Senior Clinical Protocol Manager, BRISTOL-MYERS SQUIBB

Priya Guyadeen
Clinical Project Manager, Peripheral, PENUMBRA, INC.

Shawn Keen
Associate Director, Imaging Partner Relationship Lead, BRISTOL-MYERS SQUIBB

Dr. Johan Luthman
VP Neuroscience Clinical Development, EISAI

view speaker profile

(Per) Johan Luthman is Vice President and Head of Neuroscience Clinical Development, Eisai Pharmaceuticals, where he is engaged in overseeing clinical development programs from preclinical development to phase 3 in the area of neuroscience, with current programs in Alzheimer’s disease & other dementing disorders, epilepsy, sleep disorders and obesity.

Before joining Eisai, Johan was VP and Franchise Integrator, leading translational medicine and biomarker activities in neuroscience as well as Senior Program Leader for Early Development Neuroscience & Ophthalmology at Merck Research Laboratories, based in PA, USA, overseeing projects from preclinical candidate to proof of concept in Phase 2. Prior to Merck, Johan led GeNeuro SA, Geneva, as CEO during its build-up phase to a standalone biotechnology company. Before then, Johan was SVP & Therapy Area Head of Neurology, Immunology & Inflammation Research and Head of PoC strategy in Neurology at MerckSerono, based in Geneva, CH. He joined Serono in 2005, as Head Neuroscience & Immunology Research. Johan began his pharmaceutical career in 1991 in Astra, Sodertalje, Sweden. In Astra/AstraZeneca he worked as project leader as well as director of research departments, before leading Translational Science in Neurology & Analgesia. During his years in the industry, Johan has been engaged in numerous Public-Private pre-competitive consortia efforts, including acting as chairman of the ADNI Industry group in 2012, and chair efforts within C-Path Institute.

Johan studied medicine and dentistry at the Karolinska Institute. In parallel with clinical practice, he obtained a Ph. D in neurobiology in 1989. He continued as a Research Fellow in Pharmacology & Psychiatry at the University of Colorado. Johan was subsequently appointed the associate professor in Neurobiology at Karolinska Institute and received an honorary professorship in pharmacology from the University of Chile. He obtained business training at SIMI, Copenhagen and Thunderbird and MIT/Sloan Management Institute.

Colin Miller
Editor, Medical Imaging in Clinical Trials

Youngho Seo, Ph.D.
Professor, Department of Radiology and Biomedical Imaging, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Ira Smalberg, M.D.

Gary Ulaner, M.D., Ph.D.